Perinatal neuroprotection

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Salmeen, Kirsten E ^a   Jelin, Angie C ^a   Thiet, Mari Paule ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ETIRACETAM; MAGNESIUM SULFATE; MELATONIN; PROGESTERONE; URIDINE;

ANTIBIOTIC THERAPY; BLOOD BANK; BRAIN INJURY; CHORIOAMNIONITIS; ERYTHROCYTE TRANSFUSION; GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INTRAUTERINE BLOOD TRANSFUSION; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS (TOPIC); NEUROPROTECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PERINATAL ASPHYXIA; PERINATAL PERIOD; PREGNANCY DISORDER; PREMATURE LABOR; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UMBILICAL CORD BLOOD; UMBILICAL CORD CLAMP; UROGENITAL TRACT INFECTION; VAGINITIS;

EID: 84892381116     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-6     Document Type: Review

References (91)

1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B: A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007, 109:8-14.
2. Winter S, Autry A, Boyle C, Yeargin-Allsopp M: Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002, 110:1220-5.
3. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003. MMWR Morb Mortal Wkly Rep 2004, 53:57-9.
4. Kruse M, Michelsen SI, Flachs EM, Brønnum-Hansen H, Madsen M, Uldall P: Lifetime costs of cerebral palsy. Dev Med Child Neurol 2009, 51:622-8.
5. Crowley PA: Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995, 173:322-35.
6. van de Bor M, Verloove-Vanhorick SP, Brand R, Keirse MJ, Ruys JH: Incidence and prediction of periventricular-intraventricular hemorrhage in very preterm infants. J Perinat Med 1987, 15:333-9.
7. Leviton A, Kuban KC, Pagano M, Brown ER, Krishnamoorthy KS, Allred EN: Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g. Obstet Gynecol 1988, 72:571-6.
8. Kuban KC, Leviton A, Pagano M, Fenton T, Strassfeld R, Wolff M: Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992, 7:70-6.
9. O'Shea TM, Klinepeter KL, Dillard RG: Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol 1998, 147:362-9.
10. Nelson KB, Grether JK: Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995, 95:263-9.
11. Wilson-Costello D, Borawski E, Friedman H, Redline R, Fanaroff AA, Hack M: Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics 1998, 102:315-22.
12. Mittendorf R, Dambrosia J, Pryde PG, Lee K, Gianopoulos JG, Besinger RE, Tomich PG: Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002, 186:1111-8.
13. Crowther CA, Hiller JE, Doyle LW, Haslam RR: Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003, 290:2669-76.
14. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007, 114:289-99.
15. Marret S, Marpeau L, Zupan-Simunek V, Eurin D, Lévêque C, Hellot M, Bénichou J: Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG 2007, 114:310-8.
16. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JM, Harper M, Thorp JM, Ramin SM, Malone FD, Carpenter M, Miodovnik M, Moawad A, O'Sullivan MJ, Peaceman AM, Hankins GDV, Langer O, Caritis SN, Roberts JM: A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008, 359:895-905.
17. Costantine MM, Weiner SJ: Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009, 114:354-64.
18. Conde-Agudelo A, Romero R: Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 2009, 200:595-609.
19. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009:CD004661.
20. Committee Opinion No. 573: Magnesium sulfate use in obstetrics. Obstet Gynecol 2013, 122:727-8.
21. Yokoyama K, Takahashi N, Yada Y, Koike Y, Kawamata R, Uehara R, Kono Y, Honma Y, Momoi MY: Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev 2010, 86:187-91.
22. Wedig KE, Kogan J, Schorry EK, Whitsett JA: Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 2006, 26:371-4.
23. Malaeb SN, Rassi AI, Haddad MC, Seoud MA, Yunis KA: Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol 2004, 34:384-6.
24. Nassar AH, Sakhel K, Maarouf H, Naassan GR, Usta IM: Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scand 2006, 85:1099-103.
25. FDA Drug Safety Communications: FDA Recommends against prolonged use of magnesium sulfate to stop preterm labor due to bone changes in exposed babies. [http://www.fda.gov/Drugs/DrugSafety/ucm353333.htm].
26. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365:663-70.
27. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005, 353:1574-84.
28. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, Thoresen M, Whitelaw A, Brocklehurst P: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009, 361:1349-58.
29. Simbruner G, Mittal RA, Rohlmann F, Muche R: Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 2010, 126:e771-8.
30. Zhou W, Cheng G, Shao X, Liu X, Shan R, Zhuang D, Zhou C, Du L, Cao Y, Yang Q, Wang L: Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J Pediatr 2010, 157:367-72, 372.e1-3.
31. Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, Wright IMR, Kirpalani HM, Darlow BA, Doyle LW: Whole-body hypothermia for term and near-term newborns with hypoxicischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med 2011, 165:692-700.
32. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG: Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013, 1:CD003311.
33. Barks JDE: Technical aspects of starting a neonatal cooling program. Clin Perinatol 2008, 35:765-75, vii.
34. Yao AC, Lind J: Blood flow in the umbilical vessels during the third stage of labor. Biol Neonate 1974, 25:186-93.
35. McCausland AM, Holmes F, Schumann WR: Management of cord and placental blood and its effect upon the newborn. Part II. West J Surg Obstet Gynecol 1950, 58:591-608.
36. Utility of umbilical cord blood acid-base assessment. ACOG Committee Opinion: Committee on Obstetric Practice. Number 138-April 1994. Int J Gynaecol Obstet 1994, 45:303-4.
37. Hofmeyr GJ, Bolton KD, Bowen DC, Govan JJ: Periventricular/ intraventricular haemorrhage and umbilical cord clamping. Findings and hypothesis. S Afr Med J 1988, 73:104-6.
38. Baenziger O, Stolkin F, Keel M, Siebenthal K von, Fauchere J, Das Kundu S, Dietz V, Bucher H, Wolf M: The influence of the timing of cord clamping on postnatal cerebral oxygenation in preterm neonates: a randomized, controlled trial. Pediatrics 2007, 119:455-9.
39. Bonnar J, McNicol GP, Douglas AS: The blood coagulation and fibrinolytic systems in the newborn and the mother at birth. J Obstet Gynaecol Br Commonw 1971, 78:355-60.
40. Park D, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, Chung Y, Sanberg PR: Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant 2009, 18:985-98.
41. Rabe H, Wacker A, Hülskamp G, Hörnig-Franz I, Schulze-Everding A, Harms E, Cirkel U, Louwen F, Witteler R, Schneider HP: A randomised controlled trial of delayed cord clamping in very low birth weight preterm infants. Eur J Pediatr 2000, 159:775-7.
42. McDonnell M, Henderson-Smart DJ: Delayed umbilical cord clamping in preterm infants: a feasibility study. J Paediatr Child Health 1997, 33:308-10.
43. Kinmond S, Aitchison TC, Holland BM, Jones JG, Turner TL, Wardrop CA: Umbilical cord clamping and preterm infants: a randomised trial. BMJ 1993, 306:172-5.
44. Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W: Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 2006, 117:1235-42.
45. Saigal S, Usher RH: Symptomatic neonatal plethora. Biol Neonate 1977, 32:62-72.
46. Oh W: Neonatal polycythemia and hyperviscosity. Pediatr Clin North Am 1986, 33:523-32.
47. van Rheenen P, Brabin BJ: Late umbilical cord-clamping as an intervention for reducing iron deficiency anaemia in term infants in developing and industrialised countries: a systematic review. Ann Trop Paediatr 2004, 24:3-16.
48. Saigal S, O'Neill A, Surainder Y, Chua LB, Usher R: Placental transfusion and hyperbilirubinemia in the premature. Pediatrics 1972, 49:406-19.
49. Committee Opinion No. 543: Timing of umbilical cord clamping after birth. Obstet Gynecol 2012, 120:1522-6.
50. Rabe H, Jewison A, Alvarez RF, Crook D, Stilton D, Bradley R, Holden D: Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial. Obstet Gynecol 2011, 117:205-11.
51. Carlson ES, Tkac I, Magid R, O'Connor MB, Andrews NC, Schallert T, Gunshin H, Georgieff MK, Petryk A: Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 2009, 139:672-9.
52. Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, Jimenez R, Mora LA, Gomez I, Krauskoph D: Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics 1987, 79:981-95.
53. Hutton EK, Hassan ES: Late vs early clamping of the umbilical cord in full-term neonates: systematic review and metaanalysis of controlled trials. JAMA 2007, 297:1241-52.
54. McDonald SJ, Middleton P, Dowswell T, Morris PS: Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2013, 7:CD004074.
55. Andersson O, Domellöf M, Andersson D, Hellström-Westas L: Effects of delayed cord clamping on neurodevelopment and infection at four months of age: a randomised trial. Acta Paediatr 2013, 102:525-31.
56. Eastman NJ, Deleon M: The etiology of cerebral palsy. Am J Obstet Gynecol 1955, 69:950-61.
57. Grether JK, Nelson KB: Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278:207-11.
58. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, van Marter LJ, Pagano M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Abiri M, Disalvo D, Doubilet P, Kairam R, Kazam E, Kirpekar M, Rosenfeld D, Schonfeld S, Share J, Collins M, Genest D, Shen-Schwarz S: Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999, 46:566-75.
59. Elovitz MA, Brown AG, Breen K, Anton L, Maubert M, Burd I: Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011, 29:663-71.
60. Kasdorf E, Perlman JM: Hyperthermia, inflammation, and perinatal brain injury. Pediatr Neurol 2013, 49:8-14.
61. Romero R, Savasan ZA, Chaiworapongsa T, Berry SM, Kusanovic JP, Hassan SS, Yoon BH, Edwin S, Mazor M: Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 2011, 40:19-32.
62. Wu YW, Colford JM: Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000, 284:1417-24.
63. Shatrov JG, Birch SCM, Lam LT, Quinlivan JA, McIntyre S, Mendz GL: Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 2010, 116:387-92.
64. Ahlin K, Himmelmann K, Hagberg G, Kacerovsky M, Cobo T, Wennerholm U, Jacobsson B: Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol 2013, 122:41-9.
65. Wu CS, Pedersen LH, Miller JE, Sun Y, Streja E, Uldall P, Olsen J: Risk of cerebral palsy and childhood epilepsy related to infections before or during pregnancy. PLoS ONE 2013, 8:e57552.
66. Streja E, Miller JE, Bech BH, Greene N, Pedersen LH, Yeargin-Allsopp M, van Naarden Braun K, Schendel DE, Christensen D, Uldall P, Olsen J: Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol 2013, 209:332.e1-332.e10.
67. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S: Prevention of recurrent preterm delivery by 17 alpha- hydroxyprogesterone caproate. N Engl J Med 2003, 348:2379-85.
68. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Klein K, Rode L, Soma-Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS: Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012, 206:124.e1-19.
69. Gluckman E: Milestones in umbilical cord blood transplantation. Blood Rev 2011, 25:255-9.
70. Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, Dinse HR, Dermietzel R, Jensen A: Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006, 59:244-9.
71. Pimentel-Coelho PM, Magalhães ES, Lopes LM, de Azevedo LC, Santiago MF, Mendez-Otero R: Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev 2010, 19:351-8.
72. Xia G, Hong X, Chen X, Lan F, Zhang G, Liao L: Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J Perinat Med 2010, 38:215-21.
73. Carroll J: Human cord blood for the hypoxic-ischemic neonate. Pediatr. Res 2012, 71:459-63.
74. Clinical Trials Database. [http://clinicaltrials.gov/ct2/results?term= umbilical+cord+blood+and+neonatal+brain+injury&Search=Search].
75. Aydin A, Genç K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E: Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 2003, 25:494-8.
76. Matsushita H, Johnston MV, Lange MS, Wilson MA: Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 2003, 14:1757-61.
77. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, Ulukus C, Genc S, Ozkan H: Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2003, 83:224-8.
78. Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, McQuillen PS, Ferriero DM: Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005, 58:106-11.
79. Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM: Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci 2009, 31:403-11.
80. Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G: Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 2010, 41:1032-7.
81. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K: Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 2004, 153:77-86.
82. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K, Wang X: Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009, 124:e218-26.
83. Elmahdy H, El-Mashad A, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H: Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 2010, 125:e1135-42.
84. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE: Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012, 130:683-91.
85. Cansev M, Minbay Z, Goren B, Yaylagul EO, Cetinkaya M, Koksal N, Alkan T: Neuroprotective effects of uridine in a rat model of neonatal hypoxic-ischemic encephalopathy. Neurosci Lett 2013, 542:65-70.
86. Kilicdag H, Daglioglu K, Erdogan S, Guzel A, Sencar L, Polat S, Zorludemir S: The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 2013, 89:355-60.
87. Qiu J, Zhou X, Zhou X, Cheng R, Liu H, Li Y: Neuroprotective Effects of MicroRNA-210 on Hypoxic-Ischemic Encephalopathy. Biomed Res Int 2013, 2013:350419.
88. Wang Y, Li B, Li Z, Huang S, Wang J, Sun R: Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochem Res 2013, 38:742-52.
89. Wang Z, Liu D, Zhan J, Xie K, Wang X, Xian X, Gu J, Chen W, Hao A: Melatonin improves short and long-term neurobehavioral deficits and attenuates hippocampal impairments after hypoxia in neonatal mice. Pharmacol Res 2013, 76:84-97.
90. Hung P, Huang C, Huang H, Tu D, Chang Y: Thyroxin treatment protects against white matter injury in the immature brain via brain-derived neurotrophic factor. Stroke 2013, 44:2275-83.
91. Yang L, Wang J, Tian Z, Yuan Y: Shenfu injection attenuates neonatal hypoxic-ischemic brain damage in rat. Neurol Sci 2013, 34:1571-4.